|Bid||0.0080 x N/A|
|Ask||0.0090 x N/A|
|Day's range||0.0090 - 0.0090|
|52-week range||0.0075 - 0.0500|
|Beta (5Y monthly)||0.38|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Key Insights OncoSil Medical's Annual General Meeting to take place on 28th of November CEO Nigel Lange's total...
OncoSil Medical ( ASX:OSL ) Full Year 2023 Results Key Financial Results Net loss: AU$11.3m (loss widened by 5.7% from...
OncoSil Medical Limited ( ASX:OSL ) shareholders (or potential shareholders) will be happy to see that insider Sarah...